Latest Headlines
-
AAV Producer Cell Lines, A New Standard For Viral Vector Manufacturing
10/6/2025
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its AAV Edge Stable Producer System. With this launch, Asimov aims to address the shortcomings of traditional transient transfection-based production and bring AAV manufacturing standards closer to those established for antibody-based biologics.
-
CDMO AbbVie Begins Construction On Biologics Manufacturing Facility Expansion In Massachusetts
10/2/2025
AbbVie today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.
-
Federal Equipment Company Announces Exclusive Sale Of Brand-New Aseptic Processing & Sterilization Equipment
10/2/2025
Federal Equipment Company is pleased to announce the exclusive consignment of a suite of brand-new, never-used equipment designed for pharmaceutical and biotech aseptic processing. These state-of-the-art systems from leading manufacturers are now available for immediate purchase, offering buyers a unique opportunity to acquire high-performance technologies without the typical lead times of new builds.
-
Bora Pharmaceuticals Wins Canada's Safest New Employer Award
10/1/2025
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of The Bruce Power Award for Canada’s Safest New Employer. The award, announced during the 2025 Canada’s Safest Employers ceremony in October, recognizes an exemplary safety record in less than 10 years of operation.
-
Bora Pharmaceuticals Introduces High-Potency Liquid Capsule Technology In Taiwan
9/30/2025
Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, has announced the addition of liquid-filled hard capsule (LFC) production capabilities at its Zhunan, Taiwan facility.
- Launch Of The Next Syringe Production Line 9/23/2025
- Abzena Enhances AbZelectPRO™ Cell Line Offering With New GS Knockout Platforms 9/16/2025
-
Avid Bioservices Welcomes Kenneth Bilenberg As New CEO
9/15/2025
A seasoned industry executive with more than 20 years of experience, Bilenberg most recently served as Chief Operating Officer of Fujifilm Biotechnologies, leading global operations across modalities and scale.
-
FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium To Enable Gene Therapy Production
9/15/2025
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
-
CAI Appoints Jamie Robertson As Vice President Of Mission Critical To Drive Innovation And Operational Excellence Across Global Infrastructure Projects
9/14/2025
CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the appointment of Jamie Robertson as Vice President of Mission Critical.